Evaluation of non-isomerised c-telopeptide fragments of type-I collagen (ALPHA CTX) as a novel marker of bone metabolism in patients with localised, metastasized and hormone refractory prostate cancer (PCA)

被引：0
|
作者：
Hegele, A. [1 ]
Olbert, P. [1 ]
Schrader, A. [1 ]
Wagner, R. [1 ]
Hofmann, R. [1 ]
Leaming, D. [2 ]
机构：
[1] Univ Marburg, Sch Med, Dept Urol, Marburg, Germany
[2] Nordic Biosci, Herlev, Denmark
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1569-9056(08)60539-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
543
引用
收藏
页码：206 / 206
页数：1
相关论文
共 7 条
  • [1] Evaluation of non-isomerized c-telopeptide fragments of type-I collagen (ALPHA CTX) as a novel marker of bone metabolism in patients with localized, metastasized and hormone refractory prostate cancer (PCA)
    Hegele, Axel
    Olbert, Peter J.
    Schrader, Andres J.
    Varga, Zoltan
    Hofmann, Rainer
    Leeming, Diana
    JOURNAL OF UROLOGY, 2008, 179 (04): : 182 - 182
  • [2] Measurements of non-isomerised C-telopeptides fragments of type I collagen (αCtx) for detection of bone metastases in patients with primary carcinoma
    Koizumi, M
    Leeming, DJ
    Byrjalsen, I
    Christiansen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P63 - P63
  • [3] The utility of measuring non-isomerised C-telopeptides of type I collagen (α-CTX) for early detection of the skeletal metastasis in patients with diagnosed breast or prostate cancer.
    Leeming, D
    Koizumi, M
    Christiansen, C
    Qvist, P
    Tanko, L
    Byrjalsen, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S216 - S216
  • [4] Non-isomerized fragments of type I collagen (ααCTX) as a sensitive indicator of bone metastases in prostate cancer patients.
    Leeming, D. J.
    Piedra, C. D.
    Qvist, P.
    Christiansen, C.
    Byrjalsen, I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S220 - S220
  • [5] Palliative treatment of bone metastases in hormone-refractory prostate cancer: Effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels
    Kawashima, Hidenori
    Tanaka, Tomoaki
    Kuratsukuri, Katsuyuki
    Uchida, Junji
    Sugimura, Kazunobu
    Tamada, Satoshi
    Nishisaka, Nobuyasu
    Kumata, Katsuyuki
    Iwai, Yoshihito
    Ikemoto, Shinichi
    Ezaki, Kazuyoshi
    Nakatani, Tatsuya
    UROLOGIA INTERNATIONALIS, 2007, 78 (04) : 345 - 350
  • [6] Urinary excretion and immunolocalization of non-isomerized fragments of type I collagen (ALPHA CTX) in metastatic bone disease secondary to prostate cancer
    Leeming, D. J.
    de la Piedra, C.
    Delling, G.
    Qvist, P.
    Karsdal, M.
    Henriksen, K.
    Christiansen, C.
    Byrjalsen, I.
    CANCER TREATMENT REVIEWS, 2006, 32 : S33 - S33
  • [7] Non-isomerized C-telopeptides of type I collagen (ALPHA CTX) for early detection and treatment monitoring of bone metastases secondary to prostate cancer
    Leeming, D. J.
    Hegele, A.
    Karsdal, M. A.
    Qvist, P.
    Olbert, P.
    Christiansen, C.
    Byrjalsen, I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S291 - S291
1